Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

AMBQ vs MCHPP: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AMBQ Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 3–5 Matrix Metrics)

AMBQ Overall Winner 6-Pillar Tally: AMBQ 4 – 2 MCHPP Matrix Metrics: AMBQ 3 – 5 MCHPP

As of Nov 16, 2026, Ambiq Micro, Inc. (AMBQ) is the stronger overall head-to-head candidate over Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) in the Tradestie Institutional Equity Comparison Engine, winning 3–5 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). AMBQ carries a Unified Composite Score of 46.9/100 (HOLD) at $44.59 (N/M Forward P/E, -36.0% operating margin), whereas MCHPP carries 57.1/100 (HOLD) at $52.64 (N/M Forward P/E, 21.6% operating margin).

  • Composite vs. Pillar Nuance: While MCHPP currently prints a higher short-term Unified Composite Score (57.1/100 HOLD vs. AMBQ 46.9/100 HOLD), AMBQ captures the overall institutional head-to-head verdict (3–5 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (-36.0% vs. 21.6% operating margin) and revenue trajectory (+110.0% vs. +42.2% YoY).
  • Technical & Structure Timing Caution: AMBQ is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 42.3); meanwhile MCHPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AMBQ vs MCHPP
AMBQ NYSE Head-to-Head Winner
Ambiq Micro, Inc.
Semiconductors & Related Devices
$44.59
-6.05% 1D
Market Cap $1.2B
TTM Revenue $118M
Forward P/E N/M
Beta / 30D Vol 3.71β · 125% Vol
Unified Composite Score
46.9 / 100 HOLD
Tech 53.0 Fund 58.0 Flow 65.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -8.4%), weak momentum, RSI 42
RSI-14: 42.3 · SMA20: $47.52 · SMA50: $56.35
MCHPP NASDAQ
Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock
Semiconductors & Related Devices
$52.64
-3.18% 1D
Market Cap N/A
TTM Revenue $5.60B
Forward P/E N/M
Beta / 30D Vol 2.16β · 65% Vol
Unified Composite Score
57.1 / 100 HOLD
Tech 74.0 Fund 61.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -2.8%), weak momentum, RSI 32
RSI-14: 32.3 · SMA20: $61.25 · SMA50: $63.22

6-Pillar Scorecard Institutional Category Breakdown (AMBQ 4 – 2 MCHPP)

Columns: Metric · AMBQ · MCHPP
1. Valuation Multiples AMBQ
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 7.3x N/M
2. Growth & Scale AMBQ
Revenue Growth (YoY) +110.0% +42.2%
Earnings Growth (YoY) +0.0% N/A
TTM Revenue (USD) $118M $5.60B
Market Cap $1.2B N/A
3. Profitability & Quality MCHPP
Gross Margin 44.8% 62.7%
Operating Margin -36.0% 21.6%
Net Profit Margin -29.7% 15.0%
Return on Equity (ROE) -12.2% 12.6%
4. Balance Sheet & Cash Flow MCHPP
Cash Generation (TTM) -$40M $1.87B EBITDA
Cash Flow Margin -33.8% 33.3% EBITDA Mgn
Net Cash / Leverage $359M Net Cash $12.20 Book/Sh · 12.6% ROE
Dividend Yield None (0.00%) 6.84%
5. Options & Positioning AMBQ
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 96.5% (27th %ile) N/A (N/A)
Put/Call OI Skew 2.14x (Put-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat AMBQ
OpEx & R&D Intensity 80.8% of Rev ($95M) 41.1% of Rev ($2.30B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Scale & Operating Efficiency Moat
Supply-Chain Role Semiconductors Operator Semiconductors Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AMBQ (3) vs MCHPP (5)
Institutional Metric AMBQ MCHPP Criterion Row Edge
Market Capitalization
Scale
$1.2B N/A Larger Scale AMBQ
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+110.0% +42.2% Higher Growth AMBQ
Operating Margin (TTM)
Profitability
-36.0% 21.6% Higher Margin MCHPP
Net Profit Margin
Profitability
-29.7% 15.0% Higher Margin MCHPP
Return on Equity (ROE)
Capital Efficiency
-12.2% 12.6% Higher ROE MCHPP
52-Week Range Position
Momentum
32% ($22–$92) 14% ($47–$88) Stronger Trend AMBQ
Beta / 30D Volatility
Risk Regime
3.71β · 125% Vol 2.16β · 65% Vol Lower Realized Risk MCHPP
Unified Institutional Score
Composite Signal
46.9 / 100 (HOLD) 57.1 / 100 (HOLD) Higher Composite MCHPP
Trailing 12M Revenue (USD)
Operating Scale
$118M $5.60B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
44.8% 62.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 7.3x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$40M ($359M Net Cash) $1.87B EBITDA ($12.20 Book/Sh · 12.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AMBQ +6.8 pp
AMBQ: -10.61% · MCHPP: -17.41%
3M Horizon MCHPP +7.8 pp
AMBQ: -29.23% · MCHPP: -21.43%
6M Horizon MCHPP +4.16 pp
AMBQ: -37.5% · MCHPP: -33.34%
1Y Horizon AMBQ +71.56 pp
AMBQ: +72.36% · MCHPP: +0.8%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AMBQ vs MCHPP. Trailing 12-month operating profitability (AMBQ -36.0% vs MCHPP 21.6%) and valuation multiples (AMBQ N/M vs MCHPP N/M Forward P/E) are benchmarked directly in Pillar 4 below.

AMBQ ADR TTM Benchmark FX-Normalized USD
TTM Revenue$118M
Gross Margin44.8%
Op. Margin-36.0%
ROE / Fwd P/E-12.2% · N/M
MCHPP ADR TTM Benchmark FX-Normalized USD
TTM Revenue$5.60B
Gross Margin62.7%
Op. Margin21.6%
ROE / Fwd P/E12.6% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AMBQ BREAKDOWN
104d in phase · OBV NEUTRAL
Current IV 96.5%
IV Percentile 27th %ile
Put/Call OI Skew 2.14x (Put-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact AMBQ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
MCHPP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MCHPP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AMBQ Moat Profile Cyclical / Execution-Driven Positioning
Semiconductors Operator
Competes within the Semiconductors value chain with $1.2B market capitalization and -36.0% operating margin.
OpEx & R&D Reinvestment 80.8% of Rev ($95M)
90D Engineering Disclosures 0 Published
Mapped Supply-Chain Ecosystem (15 partners):
Taiwan Semiconductor Manufacturing Company ARM Holdings Synopsys Cadence Design Systems
MCHPP Moat Profile Scale & Operating Efficiency Moat
Semiconductors Operator
Competes within the Semiconductors value chain with N/A market capitalization and 21.6% operating margin.
OpEx & R&D Reinvestment 41.1% of Rev ($2.30B)
90D Engineering Disclosures 0 Published
Mapped Supply-Chain Ecosystem (19 partners):
Taiwan Semiconductor Manufacturing Company United Microelectronics Corporation Amkor Technology ASE Technology Holding

Investor FAQ AMBQ vs MCHPP Key Questions & Quantitative Answers

As of Nov 16, 2026, Ambiq Micro, Inc. (AMBQ) is the stronger overall head-to-head candidate over Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) in the Tradestie Institutional Equity Comparison Engine, winning 3–5 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). AMBQ carries a Unified Composite Score of 46.9/100 (HOLD) at $44.59 (N/M Forward P/E, -36.0% operating margin), whereas MCHPP carries 57.1/100 (HOLD) at $52.64 (N/M Forward P/E, 21.6% operating margin). Composite vs. Pillar Nuance: While MCHPP currently prints a higher short-term Unified Composite Score (57.1/100 HOLD vs. AMBQ 46.9/100 HOLD), AMBQ captures the overall institutional head-to-head verdict (3–5 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (-36.0% vs. 21.6% operating margin) and revenue trajectory (+110.0% vs. +42.2% YoY). Technical & Structure Timing Caution: AMBQ is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 42.3); meanwhile MCHPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

AMBQ leads the Growth & Scale pillar: AMBQ posts +110.0% YoY revenue growth and +0.0% YoY earnings growth on $118M TTM revenue (44.8% gross margin, -36.0% operating margin), compared with MCHPP at +42.2% YoY revenue growth and N/A YoY earnings growth on $5.60B TTM revenue (62.7% gross margin, 21.6% operating margin). On trailing 12-month operating scale, AMBQ generates $118M in USD-normalized revenue versus $5.60B for MCHPP. In operating R&D and SG&A reinvestment, AMBQ deploys 80.8% of Rev ($95M) (0 90-day corporate R&D disclosures) versus 41.1% of Rev ($2.30B) (0 disclosures) for MCHPP.

AMBQ screens cheaper on headline valuation multiples. AMBQ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 7.3x EV/Revenue (-33.8% FCF margin), whereas MCHPP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (33.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AMBQ (-12.2% ROE) versus MCHPP (12.6% ROE) capital efficiency.

In options market volatility and institutional positioning, AMBQ carries 96.5% implied volatility (27th %ile, Balanced (25th–60th %ile)), a 2.14x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (3.71β · 125% Vol realized risk). By comparison, MCHPP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.16β · 65% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.